Exoskeleton vs. Standard Lead Apron in EVAR Procedures
PROTECT-EVAR
Radiation Exposure and Operator Musculoskeletal Strain in Endovascular Aortic Repair: a Randomized Trial of Exoskeleton vs. Standard Aprons
1 other identifier
interventional
2
1 country
1
Brief Summary
The goal of this clinical trial is to learn whether an exoskeleton-supported radiation protection system can reduce radiation exposure and musculoskeletal strain in vascular surgeons during endovascular aortic repair procedures, compared with standard lead aprons. Researchers will compare procedures performed with exoskeleton-supported protection and procedures performed with standard lead aprons. Radiation exposure, physical strain, fatigue, and discomfort will be assessed during and after procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 3, 2025
CompletedFirst Submitted
Initial submission to the registry
April 7, 2026
CompletedFirst Posted
Study publicly available on registry
April 14, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 17, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 17, 2027
April 14, 2026
April 1, 2026
1.6 years
April 7, 2026
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Operator musculoskeletal strain assessed during endovascular aortic repair procedures using shoulder load sensors.
Operator weight distribution and physical load assessed during endovascular aortic repair procedures using foot-mounted load sensors.
During each procedure
Operator radiation exposure
Operator radiation exposure measured during endovascular aortic repair procedures using real-time personal dosimetry.
During each procedure
Study Arms (2)
Exoskeleton-Supported Protection System
EXPERIMENTALEndovascular aortic repair procedures performed with an exoskeleton-supported radiation protection system with visor.
Standard Lead Apron
ACTIVE COMPARATOREndovascular aortic repair procedures performed with standard lead apron radiation protection.
Interventions
A standard lead apron used by the operator during endovascular aortic repair procedures.
An exoskeleton-supported radiation protection system with visor used by the operator during endovascular aortic repair procedures.
Eligibility Criteria
You may qualify if:
- age 35 years or older
- written informed consent obtained
- vascular surgeon with substantial experience in endovascular procedures
- active participation in endovascular aortic repair procedures as a primary operator or assistant
- high procedural volume in endovascular interventions
You may not qualify if:
- refusal or inability to provide informed consent
- medical contraindications to the use of standard lead aprons or the exoskeleton-supported radiation protection system
- health conditions preventing safe participation in study procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Clinical Hospital No. 2, Pomeranian Medical University
Szczecin, West Pomeranian Voivodeship, 70-111, Poland
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2026
First Posted
April 14, 2026
Study Start
November 3, 2025
Primary Completion (Estimated)
June 17, 2027
Study Completion (Estimated)
June 17, 2027
Last Updated
April 14, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because of the small sample size and the risk of participant identification.